Return to Article Details THE PREVALENCE AND ASSOCIATED RISK FACTORS OF REBOUND HYPERTHYROIDISM IN GRAVES’ DISEASE AFTER ANTI-THYROID DRUG DOSE REDUCTION (PARAGON STUDY) Download Download PDF